Huntsman (HUN)
(Delayed Data from NYSE)
$24.11 USD
-0.34 (-1.39%)
Updated Jun 11, 2024 04:00 PM ET
After-Market: $24.12 +0.01 (0.04%) 7:58 PM ET
3-Hold of 5 3
C Value F Growth C Momentum D VGM
Brokerage Reports
Huntsman Corporation [HUN]
Reports for Purchase
Showing records 61 - 80 ( 463 total )
Company: Huntsman Corporation
Industry: Chemical - Diversified
3Q22 First Look - 4Q Guide Pointing to ~48% Q/Q Decline
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Chemicals: 3Q22 Preview - Estimates Could Sink to Trough Levels by Year-End
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
NDR Takeaways - Facing Tough Times in Strong Fighting Shape
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Textiles Effects Sale Positive for Portfolio
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
2Q22 First Look - Strong 2Q but 3Q Guide Below Consensus
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
2Q22 Follow Up - Key Margins Weaken in 2H, to Test Where Trough Is
Provider: KEYBANC CAPITAL MARKETS
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department
Company: Huntsman Corporation
Industry: Chemical - Diversified
Provider: Zacks Investment Research
Analyst: Research Department